Close Menu

Hwang Woo-Suk is continuing his comeback. According to Nature News, Hwang has applied for a new license to work with human embryonic stem cells. The Korean science ministry is scheduled to decide on that license by this coming April. Hwang is still on trial for fraud, embezzlement, and for breaches of bioethics laws.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.